Credit Services
Fedbank Financial Services Limited (fedfina) Q1 FY27: PAT Grows 13.8% to ₹114.4 Cr
Fedbank Financial Services Limited, NSE: FEDFINA, reports a 13.8% PAT growth in Q1 FY27 to ₹114.4 Cr. Key highlights include a 38.
Fedbank Financial Services Limited, a leading retail focused NBFC specializing in Loan Against Property and Gold Loans, announces its financial results for the First Quarter (Q1 FY27). The company’s Profit After Tax (PAT) grew by 13.8% year-on-year to ₹114.4 Cr. This growth is driven by a robust performance in net interest income, which increased by 38.7% year-on-year to ₹371.9 Cr. Moreover, the operating profit surged by 49.9% year-on-year to ₹187.5 Cr, reflecting strong operational efficiency.
Financial Highlights
Key financial metrics for Q1 FY27 include:
- Net Interest Income up 38.7% YoY to ₹371.9 Cr.
- Operating Profit up 49.9% YoY to ₹187.5 Cr.
- Profit After Tax up 52.5% YoY to ₹114.4 Cr.
- Asset Under Management (AUM) increased by 34.7% YoY to ₹21,136 Cr.
- Disbursements for Q1 FY27 came in at ₹6,760 Cr, growth of 13.9% YoY.
Operational Performance
The company’s operational performance also reflects strong growth. The branch count remained stable at 757, spread across 17 states and union territories. The credit cost for Q1 stands at 0.8%, indicating efficient credit management. The company’s cost to income ratio improved to 52.8%, down by 32 basis points quarter-over-quarter.
Looking Ahead
Fedbank Financial Services Limited continues to focus on expanding its lending portfolio and enhancing customer service. With a strong financial foundation and strategic growth initiatives, the company is well-positioned to drive further expansion and profitability in the upcoming quarters.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Fedbank Financial Services Limited
Fedbank Financial Services Limited belongs to the Financial Services › Credit Services sector. Here’s a quick read on where the business and the stock stand today.
Fedbank rises 10.6% over three months, with buying pressure holding steady. The PEG of 0.71 signals undervaluation relative to growth. It is a potential re-rating candidate. D/E reaches 4.10. High leverage in this environment is a material risk the market cannot ignore. Sellers drive 1.7x the volume of buyers. Furthermore, they controlled 16 of recent sessions versus 14 for buyers — a clear distribution signal. Revenue grows at 24.2% and profits at 24.0%. The business is in good shape. Moreover, a stock that does not move despite strong fundamentals often offers better value than one already priced for perfection. Check Fundamentals of Fedbank Financial Services Limited.
Credit Services
Hdb Financial Services Limited (hdbfs) Records Profit After Tax of ₹780 Crores for Q2fy27, a Growth of 34.2% Yoy
HDB Financial Services Limited (HDBFS) reports a 34.2% YoY increase in PAT for Q2 FY27, with disbursements up 18.7% and interim dividend declared.
HDB Financial Services Limited (HDBFS) has announced its unaudited financial results for the quarter ended September 30, 2026. The company reported a Profit After Tax (PAT) of ₹780 crores, marking a significant growth of 34.2% year-on-year (YoY). Additionally, disbursements for the quarter stood at ₹18,522 crores, reflecting an 18.7% increase compared to the same period last year. Moreover, the board of directors has declared an interim dividend of ₹2 per equity share.
Financial Performance Highlights
The company’s net interest income for Q2 FY27 was ₹2,534 crores, showing a 15.6% increase YoY. Net total income rose by 11.8% to ₹3,188 crores. The pre-provisioning operating profit increased by 15.9% to ₹1,774 crores. Loan losses and provisions decreased by 2.5% to ₹730 crores. Profit before tax grew by 33.4% to ₹1,044 crores.
Asset Growth and Loan Book
The asset under management (AUM) grew by 11.6% to ₹1,24,638 crores. The gross loan book increased by 11.7% to ₹1,24,469 crores. Notably, the gross Stage 3 loans decreased to 2.43% from 2.81% a year ago, while net Stage 3 loans fell to 1.09% from 1.27%.
As a result, the provision coverage on Stage 3 assets improved to 55.00% from 54.73%. The company’s return on average assets (annualized) stood at 2.4%, and earnings per share (EPS) for the quarter were ₹9.4.
HDB Financial Services Limited continues to expand its distribution network, now spanning 1,701 branches across 1,156 cities/towns, offering a wide range of lending products through its three business verticals: Enterprise Lending, Asset Finance, and Consumer Finance.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of HDB Financial Services Limited
HDB Financial Services Limited belongs to the Financial Services › Credit Services sector. Here’s a quick read on where the business and the stock stand today.
HDB rises 10.3% over three months, with buying pressure holding steady. Industry-leading margins of 28.8% reflect exceptional pricing power and operational efficiency. The PEG of 2.47 is on the high side. However, it is acceptable for a quality compounder with a strong moat. Buyers show up with 3.4x the volume of sellers. Moreover, they dominated on 17 of recent sessions versus 13 for sellers — a healthy accumulation pattern. The business grows revenue at 14.0% and profits at 9.1%, with D/E of 0.00. The stock reflects that strength. Moreover, when fundamentals and price action align, the PEG of 2.47 premium is usually justified. Check Fundamentals of HDB Financial Services Limited.
Credit Services
Creditaccess Grameen Limited Expands its Global Lender Base with USD 175 Million Syndicated Social Loan Facility
CreditAccess Grameen Limited (NSE: CREDITACC) broadens its global lender base with a USD 175 million syndicated social loan facility, reflecting internationa.
CreditAccess Grameen Limited (NSE: CREDITACC), India’s leading rural focused inclusive financing platform, has broadened its global lender base with a USD 175 million syndicated social loan facility. This marks the fifth ECB syndication transaction successfully completed by CA Grameen over the past five years, mobilising USD 640 million till date.
Strong International Participation
Despite global macroeconomic uncertainties and heightened competition in the ECB market from FCNR (B) deposits mobilisation, the syndication transaction received strong response coupled with competitive loan pricing and secured participation from ten financial institutions across Asia and the Middle East & Africa regions.
Continued Confidence in CA Grameen’s Business Model
The transaction reflects the continued confidence of international lenders in CA Grameen’s business model and corporate governance standards. The Company currently holds around 24% of its liability profile in foreign borrowings, building a strong lender base across 15 countries.
Commenting on the transaction, Mr. Nilesh Dalvi, Chief Financial Officer, CreditAccess Grameen, remarked, “The successful closure of the USD 175 million facility at competitive pricing, amidst global macroeconomic uncertainties and heightened competition from FCNR(B) deposits mobilisation, demonstrates the strength of CA Grameen franchise and the confidence we have earned from international lenders.”
As CA Grameen continues to diversify its sources of funding, its focus remains on optimising funding costs, maintaining a robust asset-liability management (ALM) profile, and strengthening balance sheet resilience to support sustainable growth and its long-term commitment to financial inclusion.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of CREDITACCESS GRAMEEN LIMITED
CREDITACCESS GRAMEEN LIMITED belongs to the Financial Services › Credit Services sector. Here’s a quick read on where the business and the stock stand today.
CREDITACCESS falls 17.1% over three months and has not found a floor yet. D/E reaches 2.94. High leverage in this environment is a material risk the market cannot ignore. Industry-leading margins of 39.8% reflect exceptional pricing power and operational efficiency. The stock holds at 30% of its 52-week range with RSI at 39. In other words, neither side has a clear edge right now. Revenue grows at 20.9% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of CREDITACCESS GRAMEEN LIMITED.
Credit Services
Poonawalla Fincorp Limited (poonawalla) Q2fy27: Sustainable, Predictable, and Productive Performance
Poonawalla Fincorp Limited (POONAWALLA) reports Q2FY27 results with sustainable growth, a 21.8% QoQ PAT increase, and robust AUM expansion.
Poonawalla Fincorp Limited (POONAWALLA) has unveiled its Q2FY27 results, showcasing a sustainable, predictable, and productive performance. The company reported a 21.8% quarter-over-quarter (QoQ) increase in PAT, reaching ₹375 crore in Q2FY27, up from ₹308 crore in Q1FY27. The company’s asset under management (AUM) also saw strong growth, with a healthy momentum across all retail products, contributing 18% to AUM. The company’s prudent risk management and disciplined execution further bolstered its financial health.
Financial Highlights
The company’s net interest income (NII) includes fees and other income, highlighting a robust performance. The PAT increase was complemented by a 11.8% QoQ expansion in the profit pool per opportunity (PPOP), reflecting strong operating leverage. The company’s asset quality improved with a reduction in gross non-performing assets (NPA) by 17 basis points QoQ and 39 basis points year-over-year (YoY). Additionally, the company successfully expanded its gold loan branches to 550, strengthening its distribution reach.
Capital Augmentation
In April 2026, Poonawalla Fincorp Limited raised ₹2,500 crore via a qualified institutional placement, resulting in a debt-to-equity ratio of 4.30x as of September 2026. The company aims to continue growing its AUM at a CAGR of 35-40% over the next couple of years. The capital raise has provided the company with a solid foundation to scale its operations and drive future growth.
Looking ahead, Poonawalla Fincorp Limited remains committed to its vision and mission of being the most trusted financial services brand. The company’s focus on digital-first and risk-first approaches, along with its customer-centric strategy, positions it well for sustained profitability and growth.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Poonawalla Fincorp Limited
Poonawalla Fincorp Limited belongs to the Financial Services › Credit Services sector. Here’s a quick read on where the business and the stock stand today.
Poonawalla falls 8.2% over three months and has not found a floor yet. D/E reaches 3.19. High leverage in this environment is a material risk the market cannot ignore. Margins at 22.7% are impressive but need to be sustained — any compression would be a red flag. The stock holds at 42% of its 52-week range with RSI at 43. In other words, neither side has a clear edge right now. The stock rises -8.2% in three months on 51.4% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Poonawalla Fincorp Limited.
-
HCLTECH2 days agoHcl Technologies Limited (hcltech) Q2 FY27: Revenue ₹35,620cr ↑3.0% Qoq ↑11.5% Yoy
-
Consumer Cyclical2 days agoCrompton Greaves Consumer Electricals Limited Launches Instanourish Pro Multi Purpose Kettle
-
Basic Materials2 days agoGoodluck India Limited (goodluck) Recognized as Sole Qualified Bidder for Defence Artillery Shells
-
Banks - Regional2 days agoRbl Bank Limited (rblbank) Q2 FY27: Net Profit Surges 170% Yoy
-
AEQUS2 days agoAequs Limited (aequs) Announces Long-term Supply Agreements with Safran for Aerospace Applications
-
Banks - Regional2 days agoThe Karnataka Bank Limited Launches Trade Konnect Digital Platform
-
Industrials2 days agoSkipper Limited (skipper) Appoints Mr. R. N. Nayak as Non-executive Independent Director
-
Healthcare2 days agoZydus Lifesciences Limited (zyduslife) Shares New Post Hoc Analysis of Phase 3 Epics-iii Trial Showing Greater Biochemical Response with Investigational Saroglitazar
